Leaver, P. J., Jang, H. S., Vernon, S. T., & Fernando, S. L. (2020). Immune checkpoint inhibitor-mediated myasthenia gravis with focal subclinical myocarditis progressing to symptomatic cardiac disease. BMJ Case Rep.
Styl cytowania ChicagoLeaver, Phillip John, Helena Sung-In Jang, Stephen Thomas Vernon, i Suran Loshana Fernando. "Immune Checkpoint Inhibitor-mediated Myasthenia Gravis With Focal Subclinical Myocarditis Progressing to Symptomatic Cardiac Disease." BMJ Case Rep 2020.
Styl cytowania MLALeaver, Phillip John, Helena Sung-In Jang, Stephen Thomas Vernon, i Suran Loshana Fernando. "Immune Checkpoint Inhibitor-mediated Myasthenia Gravis With Focal Subclinical Myocarditis Progressing to Symptomatic Cardiac Disease." BMJ Case Rep 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..